• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[具有磷脂结构的血小板活化因子拮抗剂。1. 带有杂芳烃头基的磷脂:合成、表征及结构单元作用的测定]

[PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements].

作者信息

Kertscher H P, Ostermann G, Findeisen M, Limmer S, Gawrisch K

机构信息

Sektion Biowissenschaften, Universität Leipzig.

出版信息

Pharmazie. 1991 Aug;46(8):575-9.

PMID:1798710
Abstract

A series of analogues of platelet-activating factor (PAF) with heteroarene head groups have been synthesized, and tested for biological activities on blood platelets in vitro. In comparison with PAF most of the structural modifications exerted weak proaggregatory effects. The 4-(dimethylamino)pyridinium compound did not activate platelets but inhibited selectively PAF-induced platelet responses. These results point to a crucial role of the distance between the phosphoryl group and polar head for expression of PAF-antagonistic properties. Structural features of PAF-antagonist have been investigated by two-dimensional proton NMR spectroscopy, and proposed a model with three-dimensional structure.

摘要

一系列具有杂芳烃头部基团的血小板活化因子(PAF)类似物已被合成,并在体外对血小板的生物活性进行了测试。与PAF相比,大多数结构修饰产生的促聚集作用较弱。4-(二甲基氨基)吡啶鎓化合物不激活血小板,但能选择性抑制PAF诱导的血小板反应。这些结果表明磷酰基与极性头部之间的距离对于PAF拮抗特性的表达起着关键作用。通过二维质子核磁共振光谱研究了PAF拮抗剂的结构特征,并提出了一个具有三维结构的模型。

相似文献

1
[PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements].[具有磷脂结构的血小板活化因子拮抗剂。1. 带有杂芳烃头基的磷脂:合成、表征及结构单元作用的测定]
Pharmazie. 1991 Aug;46(8):575-9.
2
[PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships].[具有磷脂结构的血小板活化因子拮抗剂。2. 带有杂芳烃头基的磷脂及磷氮距离的变化;合成、表征及构效关系]
Pharmazie. 1991 Oct;46(10):708-11.
3
[PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship].[具有磷脂结构的血小板活化因子拮抗剂。5. 带有各种取代吡啶鎓和奎宁环鎓头基以及磷氮距离变化的丙二醇磷脂;合成、表征及构效关系]
Pharmazie. 1993 Jan;48(1):23-6.
4
[PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].[具有磷脂结构的血小板活化因子拮抗剂。4. 带有杂芳烃和杂环酶头部基团的烷基氨基甲酰磷脂以及P-N距离的变化;合成、表征及构效关系]
Pharmazie. 1992 Mar;47(3):172-4.
5
[PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
Pharmazie. 1991 Nov;46(11):772-4.
6
PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
J Lipid Mediat. 1990 Jan-Feb;2(1):21-31.
7
Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
J Lipid Mediat. 1992 Feb;5(1):23-40.
8
[PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship].[具有脂质结构的血小板活化因子拮抗剂。6. C-3位带有酰基和醚结构以及杂环头部基团的烷基丙二醇脂质;合成、表征及构效关系]
Pharmazie. 1997 Sep;52(9):672-5.
9
Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.特异性拮抗剂对血小板活化因子诱导的血小板聚集及纤溶酶原激活物释放的影响。
Biomed Biochim Acta. 1988;47(10-11):S157-60.
10
PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.新型合成醚磷脂的PAF激动和拮抗行为。II. 化学结构与抑制PAF诱导的人血小板活化之间的关系。
J Lipid Mediat. 1991 Mar-Apr;3(2):225-37.

引用本文的文献

1
Special issue for Klaus Gawrisch.献给克劳斯·高里施的特刊。
Biophys J. 2023 Mar 21;122(6):E1-E8. doi: 10.1016/j.bpj.2023.02.022. Epub 2023 Mar 15.